US FDA May See Second Straight Year of Non-User Fee Funding Cuts From Congress

The House Appropriations Agriculture, Rural Development, and FDA Subcommittee advanced the FDA’s fiscal year 2025 funding bill, beginning a likely long and difficult budget cycle. 

The FDA could see budget authority dollars reduced for a second straight year. • Source: Shutterstock

[Editor's note: A version of this article appeared previously in our sister publication, Pink Sheet.]

The US Food and Drug Administration may be headed for a second straight year of cuts to its non-user fee...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Regulation

More from Policy & Regulation